Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.415 USD | -3.95% | +6.38% | -30.97% |
May. 09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
Evolution of the average Target Price on Altimmune, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Altimmune, Inc.
Guggenheim | |
B. Riley | |
HC Wainwright | |
Goldman Sachs | |
Evercore ISI | |
JMP Securities | |
Jefferies & Co. | |
Piper Sandler |
EPS Revisions
- Stock Market
- Equities
- ALT Stock
- Consensus Altimmune, Inc.